The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer patients’ perspectives: A qualitative study of reasons for subcutaneous preference vs intravenous treatment.
 
Robert Epstein
Leadership - Diadem; Fate Therapeutics; Illumina; PinkDx; Tasso; Veracyte
Stock and Other Ownership Interests - Diadem; Fate Therapeutics; HealthRhythms; Illumina; Medocity; PinkDx; Tasso; Veracyte
Consulting or Advisory Role - Halozyme; Taiho Oncology
Research Funding - Halozyme; Taiho Oncology
Travel, Accommodations, Expenses - Diadem; Fate Therapeutics; Illumina; PinkDx; Tasso; Veracyte
 
JoAnn Krenitsky
Stock and Other Ownership Interests - HealthRhythms; Medocity; Tasso; Walgreens Boots Alliance
Consulting or Advisory Role - Halozyme; Taiho Oncology
Research Funding - Halozyme; Taiho Oncology
 
Charles Theuer
Employment - Halozyme; TRACON Pharma
Leadership - 4D Molecular Therapeutics; Halozyme; Oncternal Therapeutics; TRACON Pharma
Stock and Other Ownership Interests - 4D Molecular Therapeutics; Halozyme; Oncternal Therapeutics; TRACON Pharma
Consulting or Advisory Role - Vivaldi Biosciences
 
Phillip Sarocco
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme